Tonsillitis and Pharyngitis
Contents (8)
Tonsillitis and pharyngitis represent inflammation of the pharyngeal tissues, with tonsillitis specifically involving the palatine tonsils and pharyngitis affecting the broader pharyngeal mucosa. These conditions are among the most common acute infections encountered in primary care, affecting all age groups but with peak incidence in children and young adults. The clinical significance lies in distinguishing bacterial from viral etiologies to guide appropriate antibiotic use, prevent unnecessary treatment, and identify cases at risk for serious suppurative and non-suppurative complications. Understanding the epidemiology—viral causes account for 70-80% of cases, with Group A Streptococcus (GAS) being the most common bacterial pathogen—is essential for clinical decision-making.
Viral (70–80% of cases, the default cause)
- Respiratory viruses: rhinovirus, coronavirus, adenovirus (pharyngoconjunctival fever in swimming-pool outbreaks), influenza, parainfluenza — direct epithelial infection with cytokine-driven mucosal edema; cough, rhinorrhea, hoarseness, and conjunctivitis are the mechanistic fingerprint of diffuse airway involvement
- EBV: infects B cells via CD21, driving a reactive CD8 T-cell expansion — exudative tonsillitis, posterior cervical adenopathy, splenomegaly, and atypical lymphocytosis with a positive heterophile antibody
- CMV: infects monocytes/macrophages and epithelial/endothelial cells, producing a heterophile-negative mononucleosis syndrome in which fever and malaise dominate and pharyngitis and adenopathy are comparatively mild
- Acute retroviral syndrome (HIV): nonexudative pharyngitis with mucocutaneous ulcers, rash, and adenopathy weeks after exposure; the CDC recommends HIV RNA plus antigen/antibody testing because antibody may still be negative
- Enteroviruses: coxsackie A causes herpangina (posterior palatal vesicles) and hand-foot-and-mouth disease; HSV causes anterior gingivostomatitis
Bacterial
- Group A Streptococcus: the pathogen that changes management, since IDSA guidance targets antibiotics at GAS to prevent rheumatic fever
- Fusobacterium necrophorum: an anaerobe of the tonsillar crypts, disproportionately in adolescents/young adults, and the organism behind Lemierre syndrome
- Groups C and G Streptococcus, Arcanobacterium haemolyticum (scarlatiniform rash in a teenager with a negative strep test), Mycoplasma pneumoniae
- Sexually transmitted: Neisseria gonorrhoeae (exudative pharyngitis after receptive oral sex), secondary syphilis
- Corynebacterium diphtheriae: exotoxin-mediated necrosis producing an adherent gray pseudomembrane that bleeds when scraped — a stem cue for the unvaccinated or foreign-born patient
Non-infectious: allergic rhinitis with postnasal drip, laryngopharyngeal reflux, smoke and dry-air irritation, and — in a persistently unilateral tonsillar mass — malignancy.
Non-modifiable risk factors: age 5–15 years (peak GAS incidence and peak rheumatic fever risk), late winter/early spring seasonality, and prior rheumatic fever (marked recurrence risk).
Modifiable risk factors: crowding and close contact (daycare, schools, military barracks, households), tobacco smoke exposure, immunosuppression (adds Candida and atypical pathogens), incomplete diphtheria immunization, and unprotected oral sex.
- Viral invasion and local inflammation: Viral pathogens (rhinovirus, adenovirus, EBV, influenza, parainfluenza, coronavirus) infect respiratory epithelium, triggering local production of inflammatory cytokines (IL-6, TNF-α, IL-1) and recruitment of neutrophils and lymphocytes, resulting in mucosal edema, erythema, and exudate formation
- Bacterial adhesion and immune evasion: Group A Streptococcus uses M protein and other virulence factors to evade opsonophagocytosis, adhere to epithelial cells via hyaluronic acid mimicry (molecular mimicry), and trigger intense suppurative inflammation with neutrophil infiltration; other bacterial pathogens (S. aureus, H. influenzae, N. gonorrhoeae) similarly express adhesins and produce proteases
- Tonsillar structure and bacterial colonization: Palatine tonsils contain crypts with lymphoid tissue that create anaerobic microbial niches; bacterial pathogens colonize these crypts and breach epithelial barriers, leading to abscess formation and potential dissemination
- Post-streptococcal sequelae mechanisms: In susceptible hosts, molecular mimicry between GAS M protein and human myosin, tropomyosin, and other cardiac proteins triggers cross-reactive antibody and T-cell responses, leading to acute rheumatic fever (ARF) and post-streptococcal glomerulonephritis (PSGN); these occur in 0.3-3% of untreated GAS infections
- Viral pharyngitis: Gradual onset over 1-2 days with mild to moderate sore throat, low-grade fever, rhinorrhea, cough, hoarseness, and conjunctivitis; absence of purulent exudate is common; symptoms peak at 3-4 days and resolve within 7 days; systemic symptoms are mild
- Bacterial (GAS) pharyngitis: Abrupt onset with severe sore throat, high fever (often >38.5°C), dysphagia, and exudative tonsils (yellow or white patches); enlarged, erythematous tonsils with enlarged anterior cervical lymphadenopathy (tender, unilateral or bilateral); absence of cough and rhinorrhea help distinguish from viral causes; symptoms develop rapidly over 12-24 hours
- Scarlet fever variant of GAS: Presents with classic pharyngitis plus a sandpaper-textured rash on trunk and extremities sparing palms/soles, with strawberry tongue (white coating with red papillae initially, then red and denuded); rash typically appears 24-48 hours after fever onset and fades by 3-4 days
- Infectious mononucleosis (EBV): Severe pharyngitis with thick, adherent pseudomembrane, marked lymphadenopathy, splenomegaly, atypical lymphocytosis, and prominent systemic symptoms; may include hepatitis and risk of airway obstruction; heterophile antibody test (Monospot) or EBV serologies confirm diagnosis
- Epiglottitis and retropharyngeal abscess (red flags): Severe dysphagia, drooling, stridor, tripod positioning, and respiratory distress indicate potentially life-threatening complications; these require immediate imaging and airway management
- Peritonsillar abscess: Unilateral throat pain, fever, trismus, hot potato voice, asymmetric tonsillar enlargement with uvular deviation away from affected side, and difficulty swallowing liquids
- Clinical scoring systems (Centor/Modified Centor Criteria): The Modified Centor Score (1 point each for fever ≥38°C, no cough, swollen/exudative tonsils, tender anterior cervical lymphadenopathy; subtract 1 point for age ≥45 years) helps stratify risk: score ≥3 has ~50% probability of GAS, score 0-1 has ~10% probability; a score ≥4 or score 3 with positive rapid antigen test warrants antibiotics
- Rapid antigen detection test (RADT) and throat culture: RADT has 85-95% sensitivity and 95-99% specificity for GAS; negative RADT in patients with high pretest probability (Centor score ≥3) should be confirmed with throat culture, which remains gold standard but takes 24-48 hours; culture also identifies non-GAS pathogens
- Complete blood count and differential: Viral infections show lymphocytic predominance; GAS typically shows neutrophilic predominance with left shift; EBV shows atypical lymphocytes (>10%) and mononucleosis can present with marked lymphocytosis and thrombocytopenia
- Imaging and further workup: Lateral neck radiograph (soft tissue technique) or CT/MRI if peritonsillar or retropharyngeal abscess suspected (asymmetric swelling, unilateral symptoms); intraoral ultrasound can assess for collection; imaging unnecessary for uncomplicated pharyngitis
- EBV and other serologies: Monospot (heterophile antibody test) is rapid for acute EBV infection; EBV-specific serology (IgM and IgG antibodies to VCA, EBNA) confirms diagnosis; consider testing for other viral pathogens only in severe or prolonged cases
- Viral pharyngitis (supportive care): NSAIDs (ibuprofen 400-600 mg Q6-8H or naproxen 220-500 mg BID) or acetaminophen (650-1000 mg Q4-6H) for fever and pain; throat lozenges, salt water gargles, and hydration; antibiotics are contraindicated and ineffective; most symptoms resolve within 3-7 days
- Group A Streptococcal pharyngitis first-line antibiotics:
- Penicillin V orally (40,000 units/kg/day divided QID for 10 days; standard adult dose 250-500 mg QID) remains first-line due to excellent efficacy and lack of resistance; beta-lactam allergy low risk (cross-reactivity <1% with cephalosporins)
- Amoxicillin (50 mg/kg/day once daily or divided, up to 1000 mg daily; typical 500 mg once or twice daily) is acceptable alternative with better palatability in children
- Cephalexin 500 mg QID for 10 days for penicillin-allergic patients (cephalosporin cross-reactivity is rare; use cautiously only if no history of Type I hypersensitivity)
- Group A Streptococcal pharyngitis second-line and special situations:
- Macrolide antibiotics (azithromycin 12 mg/kg on day 1, then 6 mg/kg/day for 4 days; erythromycin 500 mg QID for 10 days) if true penicillin allergy; clarithromycin 250 mg BID for 10 days as alternative; rising macrolide resistance noted in some regions
- Clindamycin 300 mg TID for 10 days for severe infections or poor compliance (longer-acting); excellent for anaerobic coverage if abscess present
- Fluoroquinolones (moxifloxacin or levofloxacin) reserved for immunocompromised patients or treatment failures; not routine due to side effects and resistance concerns
- Symptomatic management:
Suppurative (local spread from tonsillar crypts)
- **Peritonsillar abscess (quinsy)**: pus collects between the tonsillar capsule and superior constrictor; hot potato voice, trismus, and uvular deviation away from the affected side. Needle aspiration or incision and drainage plus antibiotics covering strep and oral anaerobes — urgent, and an airway emergency if respiratory compromise develops
- Retropharyngeal abscess: spread to retropharyngeal nodes in children under ~5; neck stiffness, drooling, and widened prevertebral (retropharyngeal) soft tissue on a lateral neck film — classically more than about 7 mm at C2 or 14 mm at C6 in children, on a properly extended inspiratory film. Contrast-enhanced CT of the neck is the confirmatory study. Emergency — risk of airway obstruction and descending mediastinitis
- Lemierre syndrome: Fusobacterium septic thrombophlebitis of the internal jugular vein with septic pulmonary emboli; persistent fever and unilateral neck pain after "improving" pharyngitis, cavitary lung nodules on CT. Emergency
- Contiguous spread: otitis media, sinusitis, suppurative cervical adenitis
- Streptococcal toxic shock syndrome / necrotizing fasciitis: superantigen-driven; hypotension with a diffuse rash. Emergency
Non-suppurative (immune-mediated)
- Acute rheumatic fever: molecular mimicry; carditis, migratory polyarthritis, chorea per the AHA 2015 revised Jones criteria. Prompt antibiotics prevent it — the entire rationale for treating GAS
- Post-streptococcal glomerulonephritis: immune-complex deposition, cola-colored urine, edema, hypertension, low C3. Antibiotics do not prevent it — a favorite distractor
EBV-specific: airway obstruction from tonsillar hypertrophy (systemic corticosteroids are used for impending obstruction) and splenic rupture — an emergency; avoid contact sports for roughly the first month.
Treatment-related
- Aminopenicillin rash in EBV: a characteristic, frequently cited morbilliform eruption after amoxicillin/ampicillin (older case series reported very high rates; modern prospective estimates are closer to one-third); it is not a true IgE-mediated penicillin allergy and should not be recorded as one
- IgE-mediated anaphylaxis to penicillin (epinephrine 0.3 mg IM); cephalosporin cross-reactivity is low — on the order of a few percent — and tracks shared R1 side chains, not the beta-lactam ring
- Clindamycin: C. difficile colitis. Macrolides and fluoroquinolones: QT prolongation; fluoroquinolones carry FDA boxed warnings for tendinitis/tendon rupture and peripheral neuropathy
- Post-tonsillectomy hemorrhage: primary within 24 hours, secondary around days 5–10 as eschar sloughs — emergency
- Cough and rhinorrhea argue against strep: the single most useful discriminator in a stem. Conjunctivitis, hoarseness, oral ulcers, or diarrhea point to a virus, and IDSA advises against testing patients with these features at all — testing them only uncovers chronic carriers
- Best next step for suspected GAS is a rapid antigen test, not empiric antibiotics: per IDSA, a negative RADT in a child requires backup throat culture (high stakes for rheumatic fever), whereas in adults backup culture is not routinely needed because ARF incidence is very low
- Antibiotics prevent acute rheumatic fever but not post-streptococcal glomerulonephritis: the classic distractor. ARF follows pharyngitis only; PSGN can follow pharyngitis or impetigo
- Ampicillin/amoxicillin rash in mononucleosis: a teenager with exudative pharyngitis, posterior cervical adenopathy, and splenomegaly who develops a diffuse morbilliform rash after amoxicillin has EBV — do not label them penicillin-allergic
- **Uvula deviates away from a peritonsillar abscess**, with trismus and muffled voice; the next step is drainage plus antibiotics, not CT in a classic unilateral presentation. Drooling, stridor, and tripoding instead mean the airway comes first
- Persistent fever, unilateral neck tenderness, and cavitary lung nodules after pharyngitis = Lemierre syndrome (Fusobacterium necrophorum) — the one association examiners love in young adults
- No test of cure and no routine treatment of carriers: asymptomatic carriage with a positive test plus a viral syndrome is the trap that generates unnecessary antibiotic answers
- Recurrent tonsillitis is a frequency question: AAO-HNS uses documented episode counts over 1–3 years (Paradise criteria) to justify tonsillectomy; a single severe episode does not
- A unilaterally enlarged, firm tonsil that does not resolve in an adult is oropharyngeal carcinoma (often HPV-related) until proven otherwise — not tonsillitis